Age (years) | 65 (10) | 62 (6) | 61 (9) | 0.068 |
Males (%) | 15 | 61 | 34 | 0.108 |
SBP (mm Hg) | 131 (12) | 142 (22) | 130 (17) | 0.001* |
DBP (mm Hg) | 76 (10) | 79 (10) | 74 (10) | 0.022† |
BMI (kg/m2) | 29 (28–31) | 29 (26–34) | 28 (25–30) | 0.444 |
Cholesterol (mmol/l) | 5.5 (1.1) | 4.5 (1.1) | 4.5 (1.0) | 0.001‡ |
Triglycerides (mmol/l) | 1.3 (0.8–2.0) | 1.7 (1.2–2.6) | 1.5 (1.1–2.4) | 0.128 |
HDL (mmol/l) | 1.55 (0.35) | 1.28 (0.36) | 1.25 (0.25) | 0.001‡ |
Smokers (%) | | 13 | 3 | 0.142§ |
Previous MI (%) | | 36 | 22 | 0.576§ |
LV dysfunction (%) | | 25 | 13 | 0.582§ |
Patients with diabetes (%) | | 23 | 22 | 0.020§ |
Statin treatment (%) | | 78 | 33 | 0.007§ |
ACE inhibitor (%) | | 35 | 21 | 0.649§ |
CAS | | 1.04 (0.50–1.80) | 0.82 (0.43–1.62) | 0.481§ |
CSS | | 0.90 (0.38–1.61) | 0.77 (0.20–1.32) | 0.396§ |
Adiponectin (μg/ml) | 5.2 (3.7–6.2) | 3.0 (2.0–4.2) | 2.3 (1.8–3.0) | <0.001¶ |